Ranganathan, K. and Umadevi, K.M.R. 2019. Common oral opportunistic infections in Human Immunodeficiency Virus infection/Acquired Immunodeficiency Syndrome: Changing epidemiology; diagnostic criteria and methods; management protocols. Periodontology 2000, 80(1), pp.177-188.
Vasukutty, A., Pillarisetti, S., Choi, J., Kang, S.H. and Park, I.K. 2023. CXCR4 Targeting Nanoplatform for Transcriptional Activation of Latent HIV-1 Infected T Cells. ACS Applied Bio Materials.
Jennings, J., Shi, J., Varadarajan, J., Jamieson, P.J. and Aiken, C. 2020. The host cell metabolite inositol hexakisphosphate promotes efficient endogenous HIV-1 reverse transcription by stabilizing the viral capsid. MBio, 11(6), pp.10-1128.
Maertens, G.N., Engelman, A.N. and Cherepanov, P. 2022. Structure and function of retroviral integrase. Nature Reviews Microbiology, 20(1), pp.20-34.
Badaya, A. and Sasidhar, Y.U. 2020. Inhibition of the activity of HIV-1 protease through antibody binding and mutations probed by molecular dynamics simulations. Scientific reports, 10(1), p.5501.
Kim, J.G. and Shan, L. 2022. Beyond inhibition: A novel strategy of targeting HIV-1 protease to eliminate viral reservoirs. Viruses, 14(6), p.1179.
Bertoletti, N., Chan, A.H., Schinazi, R.F., Yin, Y.W. and Anderson, K.S. 2019. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine. Protein Science, 28(9), pp.1664-1675.
Mohammadzadeh, I., Qujeq, D., Yousefi, T., Ferns, G.A., Maniati, M. and Vaghari‐Tabari, M. 2020. CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity. IUBMB life, 72(8), pp.1603-1621.
Nastri, B.M., Pagliano, P., Zannella, C., Folliero, V., Masullo, A., Rinaldi, L., Galdiero, M. and Franci, G. 2023. HIV and drug-resistant subtypes. Microorganisms, 11(1), p.221.
Achila, O.O., Abrhaley, F., Kesete, Y., Tesfaldet, F., Alazar, F., Fisshaye, L., Gebremeskel, L., Mehari, R. and Andemichael, D. 2022. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea. PloS one, 17(7), p.e0270838.
Wang, Y., Wang, A., Wang, J., Wu, X., Sun, Y. and Wu, Y. 2022. Me-Better Drug Design Based on Nevirapine and Mechanism of Molecular Interactions with Y188C Mutant HIV-1 Reverse Transcriptase. Molecules, 27(21), p.7348.
Torres, B., Guardo, A.C., Squarcia, M., Diaz, A., Fabra, A., Caballero, M., Ugarte, A., Leal, L., Gatell, J.M., Plana, M. and Garcia, F. 2021. Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial. HIV medicine, 22(8), pp.674-681.
Tinworth, C.P. and Young, R.J. 2020. Facts, patterns, and principles in drug discovery: Appraising the rule of 5 with measured physicochemical data. Journal of medicinal chemistry, 63(18), pp.10091-10108.
Jha, V., Devkar, S., Gharat, K., Kasbe, S., Matharoo, D.K., Pendse, S., Bhosale, A. and Bhargava, A. 2022. Screening of phytochemicals as potential inhibitors of breast cancer using structure based multitargeted molecular docking analysis. Phytomedicine plus, 2(2), p.100227.
Apebende, C.G., Ogunwale, G.J., Louis, H., Benjamin, I., Kadiri, M.T., Owen, A.E. and Manicum, A.L.E. 2023. Density functional theory (DFT) computation of pristine and metal-doped MC59 (M= Au, Hf, Hg, Ir) fullerenes as nitrosourea drug delivery systems. Materials Science in Semiconductor Processing, 158, p.107362.
Turković, N., 2021. Dizajniranje, sinteza i in vitro ispitivanja derivata propiofenona kao potencijalnih inhibitora enzima HIV-1 proteaze. Универзитет у Београду.
Chen, T., et al., Algorithm selection for protein–ligand docking: strategies and analysis on ACE. Scientific Reports, 2023. 13(1): p. 8219.